Tributes have poured in after the former MP, MEP and Brexit champion Ann Widdecombe passed away aged 78. Having served as the ...

Harry Styles calmly fixed a wardrobe malfunction during the final night of his Wembley residency, prompting amused reactions ...

Don't miss our daily roundup. Stay informed with a handpicked selection of the day's top AOL stories, delivered to your inbox. Thanks for signing up. Thank you for signing up. You will receive a ...

President Donald Trump says Iran is meeting U.S. demands but warns Washington will act if negotiations fail, while Tehran says it is proceeding “with vigilance” amid ongoing nuclear talks. President ...

Keir Starmer becomes the sixth Prime Minister over the past decade to resign, surrendering to the U.K.’s manifold problems.

SOUTHAMPTON, N.Y. -- Wyndham Clark has a chance to make some history on Sunday. The 2023 U.S. Open champion looks to go wire-to-wire for his second major title as he begins his final round with a ...

Logitech's folding mouse may fit in your pocket or backpack, but it won't offer the perfect PC controls we hoped for. Reading time 4 minutes The Logitech Mobi Fold is the kind of mouse that draws ...

An effort to create a new cyber-focused military service under the Army narrowly failed in the Senate, but the lawmaker who proposed it isn’t backing down. Last month, Defense One exclusively reported ...

Oregon’s behavioral health system fails to serve most of our acutely ill and vulnerable residents, which directly contributes to our state’s homelessness crisis. The recent ruling by U.S. District ...

When I was living with an eating disorder as a child, the obsessive thoughts driving how I felt about my body looked a lot like OCD. The anxiety that followed me to the dinner table didn’t go away ...

Apartment Therapy and Yahoo may earn commission from links in this article. I don’t know if I’ve ever left T.J. Maxx with just one thing — I might go looking for something specific, but invariably ...

Praxis Precision Medicines’ epilepsy pipeline has suffered a setback after a next-gen NaV blocker failed to sufficiently reduce seizures in a phase 2/3 study. The Boston-based biotech had been ...